Together with our findings on TMEM176B and PD‐L1, these data suggest that thiol isomerase inhibition can reprogram the tumor microenvironment by disrupting both immune evasion and stromal activation, creating a milieu more permissive to immune clearance and less conducive to metastatic spread. Here, TMEM176B is linked to neoplasm.